SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a number one well being and wellness firm with merchandise designed to activate optimum well being processes, right this moment introduced that the Company’s Board of Directors has accepted a quarterly money dividend of $0.035 per share of frequent inventory, which will likely be paid December 15, 2023 to all stockholders of file on the shut of business on December 1, 2023.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the activation firm, is a pioneer in nutrigenomics, the research of how vitamin and naturally occurring compounds have an effect on human genes to help good well being. The Company engages within the identification, analysis, growth, formulation and sale of superior nutrigenomic activators, dietary dietary supplements, nootropics, pre- and pro-biotics, weight administration, pores and skin and hair care, bathtub & physique, and focused reduction merchandise. The Company’s line of scientifically-validated dietary dietary supplements contains its flagship Protandim® household of merchandise, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary dietary supplements, the TrueScience® line of pores and skin, hair, bathtub & physique, and focused reduction merchandise. The Company additionally markets and sells Petandim®, its companion pet complement formulated to fight oxidative stress in dogs, Axio® its nootropic vitality drink mixes, and PhysIQ, its good weight administration system. LifeVantage was based in 2003 and is headquartered in Lehi, Utah. For extra info, go to www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This doc incorporates forward-looking statements made pursuant to the secure harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with present prospects, in addition to phrases equivalent to “believe,” “will,” “hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,” “anticipates,” “look forward to,” “goal,” “may be,” and variations thereof, determine forward-looking statements, however their absence doesn’t imply {that a} assertion will not be forward-looking. The declaration and/or cost of a dividend throughout any quarter supplies no assurance as to future dividends, and the timing and quantity of future dividends, if any, may differ considerably compared each to previous dividends and to present expectations. Examples of forward-looking statements embrace, however will not be restricted to, statements we make relating to executing in opposition to and the advantages of our key initiatives, future progress, together with geographic and product growth, the affect of COVID-19 on our business, anticipated monetary efficiency, and anticipated dividend funds in future quarters. Such forward-looking statements will not be ensures of efficiency and the Company’s precise outcomes may differ materially from these contained in such statements. These forward-looking statements are primarily based on the Company’s present expectations and beliefs regarding future occasions affecting the Company and contain recognized and unknown dangers and uncertainties which will trigger the Company’s precise outcomes or outcomes to be materially totally different from these anticipated and mentioned herein. These dangers and uncertainties embrace, amongst others, additional deterioration to the worldwide financial and working environments because of future COVID-19 developments, in addition to these mentioned in better element within the Company’s Annual Report on Form 10-Okay and the Company’s Quarterly Report on Form 10-Q underneath the caption “Risk Factors,” and in different paperwork filed by the Company every so often with the U.S. Securities and Exchange Commission (the “SEC”). The Company cautions buyers to not place undue reliance on the forward-looking statements contained on this doc. All forward-looking statements are primarily based on info at present available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to mirror occasions or circumstances after the date of this doc, besides as required by regulation.
Investor Relations Contacts:
Reed Anderson, ICR
(646) 277-1260
[email protected]
